Calamos Advisors LLC

SEC CIK: 0001316507
Latest filing: Jul 31, 2026

SEC filings (opens in a new tab)

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Calamos Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overview All 13F holders of ALNY Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2025

Holdings of ALNY by Calamos Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−1,000−100.0%	Sold out	Holders
Q4 2025	1,000	$397.6K	<0.1%	−200−16.7%	Reduced	Holders
Q3 2025	1,200	$547.2K	<0.1%	+1,200	New	Holders